11
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Availability of overdose resuscitation facilities: a survey of drug agencies in England and Wales

, , , &
Pages 99-102 | Accepted 30 Sep 1999, Published online: 12 Jul 2009
 

Abstract

Overdose is a common cause of death among intravenous drug users, with an inadequate response of witnesses cited as a contributory factor. Drug agencies provide a potential site for intervention both in acute management of overdose and in provision of overdose-related training to staff and clients. Five hundred and thirty-nine drug agencies in England and Wales were surveyed by postal questionnaire to assess the provision of resuscitation facilities and training for the management of opiate overdose as well as the agencies own experience of on-site overdose. Three hundred and fifty-six (66%) agencies returned questionnaires suitable for analysis. Although over 80% of agencies had staff trained in resuscitation, less than a quarter had access to either oxygen or naloxone. Over 20% of the agencies had witnessed an overdose on site, with eight having administered resuscitation prior to transfer to hospital. Only a third of agencies provided clients with any training in the management of overdose. It is suggested that drug agencies should provide basic resuscitation facilities and client training in the management of overdose, with protocols to ensure effective application.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.